comparemela.com

Leopold Bertea News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Mendus to present at Cell & Gene Therapy Manufacturing & Commercialization Conference in Dublin on December 4-6

Press Release Stockholm, Sweden, December 5, 2023 Mendus AB , a biopharmaceutical company focused on immunotherapies addressing tumor recurrence, today announced it will present the.

United statesErik mantingLeopold berteaAmerican society of hematologyGene therapy manufacturingCommercialization conferenceChief technology officer leopold berteaCell therapy manufacturingNorthx biologicsRobust industrial manufacturing processCancer maintenance treatmentNasdaq stockholmAmerican societyOrphan drug designationFast track designation

Mendus will participate in multiple investor and industry conferences in October and announces presentation of ALISON trial update at SITC

Mendus AB , a biopharmaceutical company focused on immunotherapies addressing tumor recurrence, today announced its participation in the following upcoming investor and industry conferences: LSX.

City ofUnited kingdomUnited statesSan diegoSan diego convention centerFrance generalCorey davisErik mantingMario brkuljLotta fermLeopold berteaLifesci advisorsSociety for the immunotherapy of cancerNordic congressValency communicationsCompany update

Mendus receives ATMP certificate from European Medicines Agency supporting its lead pipeline program vididencel

POSITIVE RECOMMENDATION BY COMMITTEE FOR ADVANCED THERAPIES CONFIRMS QUALITY OF THE MANUFACTURING PROCESS AND PRECLINICAL DATA SUBMITTED Mendus AB , a biopharmaceutical company focused on. | June 19, 2023

Erik mantingMario brkuljLeopold berteaCorey davisEuropean medicines agencyValency communicationsCommittee for advanced therapiesLifesci advisorsAdvanced therapy medicinal productAdvanced therapiesChief technology officerNasdaq stockholmSci advisorsMendus ab publ stock exchangePress releaseOcused immu se0005003654

Mendus AB: Mendus and NorthX Biologics to enter into strategic cell therapy manufacturing alliance supported by new investor Flerie

Mendus AB , a biopharmaceutical company focused on immunotherapies addressing tumor recurrence, today announces that it has entered into a manufacturing alliance with NorthX Biologics AB . NorthX is a. | June 8, 2023

City ofUnited kingdomCorey davisErik mantingHelena strigVan herkMario brkuljLeopold berteaThomas elderedManufacturing organizationValency communicationsContract developmentNational swedish innovation hubFourth swedish national pension fundLifesci advisorsNorthx biologics

Mendus AB: Mendus secures manufacturing partner for establishing potential pivotal trial-stage and commercial production of DCP-001

TECH TRANSFER ALIGNS WITH CLINICAL DEVELOPMENT STRATEGY FOR DCP-001 Mendus AB , a biopharmaceutical company focused on immunotherapies addressing tumor recurrence, today announced an agreement to. | October 18, 2022

Mario brkuljErik mantingLeopold berteaCorey davisLifesci advisorsEuropean society of gynecological oncologyValency communicationsMinaris regenerative medicine gmbhAcute myeloid leukemiaChief technology officerEuropean societyGynecological oncologySci advisorsMendus ab publ stock exchangePress releaseGreement immu se0005003654

vimarsana © 2020. All Rights Reserved.